Knight Therapeutics | GUD - 销售收入

金融业

CAD

CAD 1.05B

现金及等价物

CAD 76.45M

CAD 82.22M

CAD 394.84M

CAD 165.26M

CAD 77.91M

CAD 6.21M

CAD 24.45M

698

EPS每股收益

CAD 0.13

股本和储备

CAD 767.27M

CAD 64.72M

债务利息支出

CAD 3.92M

CAD 2.46M

CAD 57.78M

CAD 841.74M

CAD -3.79M

CAD 126.9M

CAD 6.21M

普通股股本

CAD 99.68M

257.34

CAD -1.92M

CAD 133.11M

销售和管理费用

CAD 35.45M

CAD 95.4M

贸易债权人

CAD 125.76M

应收帐款人

CAD 183M

	销售	更改		日
Acasti Pharma	USD -4.76M		4.76M	2024-12
Akebia Therapeutics	USD 57.62M		1.14M	2025-12
Alaunos Therapeutics	USD 2K		2K	2025-03
Aurora Cannabis	CAD 94.19M		3.82M	2025-12
Avita Medical	AUD 17.61M		805K	2025-12
Canopy Growth	CAD 74.54M		7.86M	2025-12
Cronos Group	USD 58.97M		580K	2026-03
Dianthus Therapeutics	USD 284K		112K	2025-12
Ionis Pharmaceuticals	USD 246M		43M	2026-03
IQVIA Holdings	USD 4.15B		210M	2026-03
Knight Therapeutics	CAD 133.11M		11.56M	2025-12
Moderna	USD 389M		289M	2026-03
Organigram Holdings	CAD 63.54M		16.52M	2025-12
Organon & Co	USD 1.46B		50M	2026-03
Revvity	USD 711M		61.06M	2026-03
Tectonic Therapeutic	USD 0		0	2024-12
Tilray	USD 217.51M		74.75M	2025-12
Viatris	USD 3.52B		180M	2026-03
Xeris Pharmaceuticals	USD 83.13M		2.68M	2026-03